Related Experiment Video
Updated: Jun 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Hypercholesterolemia and microvascular dysfunction: interventional strategies
Phoebe A Stapleton1, Adam G Goodwill, Milinda E James
1Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, 1 Medical Center Drive, Morgantown, WV 26506, USA. jfrisbee@hsc.wvu.edu.
Insights
High cholesterol (hypercholesterolemia) increases cardiovascular risk. This review examines how cholesterol-lowering drugs and exercise impact inflammation, oxidative stress, and microvascular function in hypercholesterolemia.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Exercise Physiology
Background:
- Hypercholesterolemia, high cholesterol levels, is a major risk factor for cardiovascular diseases like peripheral vascular disease (PVD) and coronary artery disease (CAD).
- Elevated cholesterol is linked to endothelial dysfunction, reduced nitric oxide, increased oxidative stress, and inflammation, impairing vascular reactivity.
Purpose of the Study:
- To review the mechanistic effects of pharmaceutical interventions and chronic exercise on hypercholesterolemia.
- To analyze impacts on chronic inflammation, oxidative stress, and microvascular structure and function.
Main Methods:
- Literature review of pharmaceutical therapies for hypercholesterolemia.
- Analysis of studies on the effects of chronic physical activity on cardiovascular risk factors and vascular function.
Main Results:
- Pharmaceuticals decrease cholesterol by inhibiting synthesis or absorption, offering direct vascular benefits.
- Physical activity reduces PVD/CAD risk factors and improves high-density lipoprotein, cardiac, and vascular function.
Conclusions:
- Both pharmaceutical treatments and exercise demonstrate pleiotropic effects beneficial for vascular health in hypercholesterolemia.
- Understanding these mechanisms is crucial for managing hypercholesterolemia and preventing cardiovascular events.
Abstract:
Hypercholesterolemia is defined as excessively high plasma cholesterol levels, and is a strong risk factor for many negative cardiovascular events. Total cholesterol levels above 200 mg/dl have repeatedly been correlated as an independent risk factor for development of peripheral vascular (PVD) and coronary artery disease (CAD), and considerable attention has been directed toward evaluating mechanisms by which hypercholesterolemia may impact vascular outcomes; these include both results of direct cholesterol lowering therapies and alternative interventions for improving vascular function. With specific relevance to the microcirculation, it has been clearly demonstrated that evolution of hypercholesterolemia is associated with endothelial cell dysfunction, a near-complete abrogation in vascular nitric oxide bioavailability, elevated oxidant stress, and the creation of a strongly pro-inflammatory condition; symptoms which can culminate in profound impairments/alterations to vascular reactivity. Effective interventional treatments can be challenging as certain genetic risk factors simply cannot be ignored. However, some hypercholesterolemia treatment options that have become widely used, including pharmaceutical therapies which can decrease circulating cholesterol by preventing either its formation in the liver or its absorption in the intestine, also have pleiotropic effects with can directly improve peripheral vascular outcomes. While physical activity is known to decrease PVD/CAD risk factors, including obesity, psychological stress, impaired glycemic control, and hypertension, this will also increase circulating levels of high density lipoprotein and improving both cardiac and vascular function. This review will provide an overview of the mechanistic consequences of the predominant pharmaceutical interventions and chronic exercise to treat hypercholesterolemia through their impacts on chronic sub-acute inflammation, oxidative stress, and microvascular structure/function relationships.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Peripheral Artery Disease III: Interprofessional Care
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis IV: Nursing Management
Coronary Artery Disease IV: Preventive Measures
